Chronic lymphocytic leukemia (CLL) often causes no symptoms at first. Many people learn they have it after a routine blood test shows a high lymphocyte count. When CLL leukemia symptoms do appear, the most common are painless swollen lymph nodes, tiredness, frequent infections, and fullness under the left ribs from an enlarged spleen. Management strategies range from careful monitoring, known as “watch and wait”, to targeted oral drugs. Treatment is started only when the disease is active or causing problems.
This guide explains how CLL behaves, which symptoms matter, how it is staged, and how treatment decisions are made.
What Is Chronic Lymphocytic Leukemia?
CLL is a slow-growing cancer of B lymphocytes, the white blood cells that make antibodies. It is one of several hematologic malignancies. In CLL, mature-looking but dysfunctional B cells build up in the blood, lymph nodes, spleen and bone marrow.
It is the most common leukemia in adults in Western countries. It is mainly a disease of older people and is usually diagnosed around age 70. Having a first-degree relative with CLL raises the risk, and exposure to some agricultural chemicals has also been linked to it. In most people, though, no clear cause is found.
CLL Leukemia Symptoms: What to Look For
Because CLL progresses slowly, symptoms tend to creep in gradually. They come from three processes: abnormal cells building up in lymph tissue, normal marrow being crowded out, and a weakened immune system.
- Swollen lymph nodes: These are usually painless, rubbery lumps in the neck, armpits or groin.
- Fatigue: Often the earliest complaint. It is sometimes caused by anemia, but not always.
- Frequent or slow-to-clear infections: Chest, sinus and skin infections, plus shingles. They reflect low antibody levels (hypogammaglobulinemia) and immune dysfunction.
- Abdominal fullness: An enlarged spleen (splenomegaly) can cause early satiety or discomfort under the left ribs.
- “B symptoms”: Unexplained fevers, drenching night sweats, and unintentional weight loss.
- Easy bruising or bleeding: Caused by low platelets as the marrow becomes crowded.
CLL can also cause autoimmune cytopenias, in which the immune system attacks the body’s own red cells or platelets. A sudden drop in hemoglobin or platelets in someone with CLL is not always progression. In my practice, this is one of the first things I check for, because it is treated differently.
How CLL Is Diagnosed and Staged
The diagnosis rests on a complete blood count and flow cytometry of the blood. CLL is defined by at least 5,000 clonal B cells per microliter of blood persisting for three months or more. Those cells carry a typical marker pattern: CD5, CD19 and CD23 positive, with weak CD20 and weak surface immunoglobulin.
A bone marrow biopsy is not always needed at diagnosis. It is usually done before treatment or to explain low blood counts. Before treatment starts, genetic tests look for del(17p) or TP53 mutations and check IGHV mutation status, because these strongly influence which drugs will work best.
| Rai stage | Findings | Risk group |
|---|---|---|
| 0 | Lymphocytosis only | Low |
| I | Lymphocytosis plus enlarged lymph nodes | Intermediate |
| II | Lymphocytosis plus enlarged spleen or liver | Intermediate |
| III | Lymphocytosis plus anemia (hemoglobin below 11 g/dL) | High |
| IV | Lymphocytosis plus low platelets (below 100,000/µL) | High |
Outside the United States, the Binet system is often used instead. It groups patients as A, B or C based on how many lymph node areas are involved and whether anemia or low platelets are present.
Management Strategies for CLL
Active Monitoring (“Watch and Wait”)
For early-stage CLL without symptoms, starting treatment early has not been shown to help people live longer. Instead, patients have blood counts and examinations every few months. This is not neglect. It spares people drug side effects for what may be many years of stable disease.
When Treatment Starts
International criteria recommend treatment for active disease. That includes worsening anemia or low platelets, bulky or progressive lymph nodes or spleen, a lymphocyte count that is doubling rapidly, troublesome B symptoms, or autoimmune cytopenias that don’t respond to standard therapy. A high lymphocyte count alone is not a reason to treat.
Targeted Therapies
Most patients who need treatment now receive targeted drugs rather than traditional chemotherapy. BTK inhibitors, such as ibrutinib, acalabrutinib and zanubrutinib, are daily tablets usually taken continuously. The BCL-2 inhibitor venetoclax is typically combined with an anti-CD20 antibody such as obinutuzumab and given for a fixed period.
Chemoimmunotherapy
The combination of fludarabine, cyclophosphamide and rituximab (FCR) was once standard for fit patients. It is now used far less. Its role is mostly limited to selected younger patients with mutated IGHV and no TP53 abnormality. Chemotherapy works poorly when del(17p) or a TP53 mutation is present.
Supportive Care
- Inactivated vaccines, including pneumococcal, influenza and non-live shingles vaccines. Live vaccines should generally be avoided.
- Immunoglobulin replacement for people with low antibody levels and repeated serious infections
- Regular skin checks, since second skin cancers are more common in CLL
Complications to Be Aware Of
Beyond infections and autoimmune cytopenias, a small minority of patients develop Richter transformation. This is a change into an aggressive lymphoma, usually signaled by rapidly growing lymph nodes, fevers, and a sharp rise in LDH. Understanding CLL alongside other blood disorders helps patients and caregivers recognize when a change needs prompt attention.
When to See a Doctor
See a doctor if you notice lymph node swelling that lasts longer than a few weeks, persistent unexplained fatigue, night sweats, or weight loss. If you already have CLL, contact your team promptly about:
- Fever, or an infection that isn’t improving
- A lymph node that grows quickly
- New breathlessness, pallor, or dark urine, which may suggest hemolysis
- New bruising, nosebleeds, or bleeding gums
Frequently Asked Questions
Is CLL curable?
For most people, CLL is treated as a long-term chronic condition rather than something that is cured. Modern targeted drugs can control it for many years. Many people with early-stage disease never need treatment.
Why is my doctor not treating my CLL right away?
Starting treatment before CLL is active has not been shown to extend life, and it adds side effects. Monitoring lets treatment begin at the point where it clearly helps.
What are the first symptoms of CLL?
Often there are none. The earliest clue is usually a raised lymphocyte count on a routine blood test. When symptoms do appear first, the most common are painless swollen lymph nodes and fatigue.
Can I live a normal life with CLL?
Many people with CLL work, travel and stay active. The main day-to-day precautions are staying up to date on appropriate vaccines, acting quickly on fevers, and keeping regular follow-up appointments.
To learn how CLL compares with other types, see our leukemia guide.
